世界のソフトカプセル医薬品CMO市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Soft Capsules Drugs CMO Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5355 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ソフトカプセル医薬品CMOのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゼラチンタイプ、非動物タイプ）、用途別市場規模（健康補助食品、医薬品、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ソフトカプセル医薬品CMOの市場動向 ・企業の競争状況、市場シェア ・ソフトカプセル医薬品CMOの種類別市場規模（ゼラチンタイプ、非動物タイプ） ・ソフトカプセル医薬品CMOの用途別市場規模（健康補助食品、医薬品、その他） ・ソフトカプセル医薬品CMOの北米市場規模2016-2027（アメリカ、カナダ） ・ソフトカプセル医薬品CMOのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ソフトカプセル医薬品CMOのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ソフトカプセル医薬品CMOの中南米市場規模2016-2027（メキシコ、ブラジル） ・ソフトカプセル医薬品CMOの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Catalent、Aenova、Nature's Bounty、Procaps、Patheon (Thermo Fisher Scientific)、IVC、EuroCaps、Captek、Strides Pharma Science、Lonza (Capsugel)、Soft Gel Technologies、Sirio Pharma） ・結論

The company supply Softgel Capsule contract pharmaceutical manufacturing services

Market Analysis and Insights: Global Soft Capsules Drugs CMO Market
The global Soft Capsules Drugs CMO market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Soft Capsules Drugs CMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Soft Capsules Drugs CMO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Soft Capsules Drugs CMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Soft Capsules Drugs CMO market.

Global Soft Capsules Drugs CMO Scope and Market Size
Soft Capsules Drugs CMO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Soft Capsules Drugs CMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gelatin Type
Non-animal Type

Segment by Application
Health Supplements
Pharmaceutical
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Catalent
Aenova
Nature’s Bounty
Procaps
Patheon (Thermo Fisher Scientific)
IVC
EuroCaps
Captek
Strides Pharma Science
Procaps

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs CMO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gelatin Type
1.2.3 Non-animal Type
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs CMO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Health Supplements
1.3.3 Pharmaceutical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Soft Capsules Drugs CMO Market Perspective (2016-2027)
2.2 Soft Capsules Drugs CMO Growth Trends by Regions
2.2.1 Soft Capsules Drugs CMO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Soft Capsules Drugs CMO Historic Market Share by Regions (2016-2021)
2.2.3 Soft Capsules Drugs CMO Forecasted Market Size by Regions (2022-2027)
2.3 Soft Capsules Drugs CMO Industry Dynamic
2.3.1 Soft Capsules Drugs CMO Market Trends
2.3.2 Soft Capsules Drugs CMO Market Drivers
2.3.3 Soft Capsules Drugs CMO Market Challenges
2.3.4 Soft Capsules Drugs CMO Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Soft Capsules Drugs CMO Players by Revenue
3.1.1 Global Top Soft Capsules Drugs CMO Players by Revenue (2016-2021)
3.1.2 Global Soft Capsules Drugs CMO Revenue Market Share by Players (2016-2021)
3.2 Global Soft Capsules Drugs CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Soft Capsules Drugs CMO Revenue
3.4 Global Soft Capsules Drugs CMO Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs CMO Revenue in 2020
3.5 Soft Capsules Drugs CMO Key Players Head office and Area Served
3.6 Key Players Soft Capsules Drugs CMO Product Solution and Service
3.7 Date of Enter into Soft Capsules Drugs CMO Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Soft Capsules Drugs CMO Breakdown Data by Type
4.1 Global Soft Capsules Drugs CMO Historic Market Size by Type (2016-2021)
4.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2022-2027)

5 Soft Capsules Drugs CMO Breakdown Data by Application
5.1 Global Soft Capsules Drugs CMO Historic Market Size by Application (2016-2021)
5.2 Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Soft Capsules Drugs CMO Market Size (2016-2027)
6.2 North America Soft Capsules Drugs CMO Market Size by Type
6.2.1 North America Soft Capsules Drugs CMO Market Size by Type (2016-2021)
6.2.2 North America Soft Capsules Drugs CMO Market Size by Type (2022-2027)
6.2.3 North America Soft Capsules Drugs CMO Market Size by Type (2016-2027)
6.3 North America Soft Capsules Drugs CMO Market Size by Application
6.3.1 North America Soft Capsules Drugs CMO Market Size by Application (2016-2021)
6.3.2 North America Soft Capsules Drugs CMO Market Size by Application (2022-2027)
6.3.3 North America Soft Capsules Drugs CMO Market Size by Application (2016-2027)
6.4 North America Soft Capsules Drugs CMO Market Size by Country
6.4.1 North America Soft Capsules Drugs CMO Market Size by Country (2016-2021)
6.4.2 North America Soft Capsules Drugs CMO Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Soft Capsules Drugs CMO Market Size (2016-2027)
7.2 Europe Soft Capsules Drugs CMO Market Size by Type
7.2.1 Europe Soft Capsules Drugs CMO Market Size by Type (2016-2021)
7.2.2 Europe Soft Capsules Drugs CMO Market Size by Type (2022-2027)
7.2.3 Europe Soft Capsules Drugs CMO Market Size by Type (2016-2027)
7.3 Europe Soft Capsules Drugs CMO Market Size by Application
7.3.1 Europe Soft Capsules Drugs CMO Market Size by Application (2016-2021)
7.3.2 Europe Soft Capsules Drugs CMO Market Size by Application (2022-2027)
7.3.3 Europe Soft Capsules Drugs CMO Market Size by Application (2016-2027)
7.4 Europe Soft Capsules Drugs CMO Market Size by Country
7.4.1 Europe Soft Capsules Drugs CMO Market Size by Country (2016-2021)
7.4.2 Europe Soft Capsules Drugs CMO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Soft Capsules Drugs CMO Market Size (2016-2027)
8.2 Asia-Pacific Soft Capsules Drugs CMO Market Size by Type
8.2.1 Asia-Pacific Soft Capsules Drugs CMO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Soft Capsules Drugs CMO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Soft Capsules Drugs CMO Market Size by Type (2016-2027)
8.3 Asia-Pacific Soft Capsules Drugs CMO Market Size by Application
8.3.1 Asia-Pacific Soft Capsules Drugs CMO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Soft Capsules Drugs CMO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Soft Capsules Drugs CMO Market Size by Application (2016-2027)
8.4 Asia-Pacific Soft Capsules Drugs CMO Market Size by Region
8.4.1 Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Soft Capsules Drugs CMO Market Size (2016-2027)
9.2 Latin America Soft Capsules Drugs CMO Market Size by Type
9.2.1 Latin America Soft Capsules Drugs CMO Market Size by Type (2016-2021)
9.2.2 Latin America Soft Capsules Drugs CMO Market Size by Type (2022-2027)
9.2.3 Latin America Soft Capsules Drugs CMO Market Size by Type (2016-2027)
9.3 Latin America Soft Capsules Drugs CMO Market Size by Application
9.3.1 Latin America Soft Capsules Drugs CMO Market Size by Application (2016-2021)
9.3.2 Latin America Soft Capsules Drugs CMO Market Size by Application (2022-2027)
9.3.3 Latin America Soft Capsules Drugs CMO Market Size by Application (2016-2027)
9.4 Latin America Soft Capsules Drugs CMO Market Size by Country
9.4.1 Latin America Soft Capsules Drugs CMO Market Size by Country (2016-2021)
9.4.2 Latin America Soft Capsules Drugs CMO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Soft Capsules Drugs CMO Market Size (2016-2027)
10.2 Middle East & Africa Soft Capsules Drugs CMO Market Size by Type
10.2.1 Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2016-2027)
10.3 Middle East & Africa Soft Capsules Drugs CMO Market Size by Application
10.3.1 Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2016-2027)
10.4 Middle East & Africa Soft Capsules Drugs CMO Market Size by Country
10.4.1 Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Soft Capsules Drugs CMO Introduction
11.1.4 Catalent Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.1.5 Catalent Recent Development
11.2 Aenova
11.2.1 Aenova Company Details
11.2.2 Aenova Business Overview
11.2.3 Aenova Soft Capsules Drugs CMO Introduction
11.2.4 Aenova Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.2.5 Aenova Recent Development
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Details
11.3.2 Nature’s Bounty Business Overview
11.3.3 Nature’s Bounty Soft Capsules Drugs CMO Introduction
11.3.4 Nature’s Bounty Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.3.5 Nature’s Bounty Recent Development
11.4 Procaps
11.4.1 Procaps Company Details
11.4.2 Procaps Business Overview
11.4.3 Procaps Soft Capsules Drugs CMO Introduction
11.4.4 Procaps Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.4.5 Procaps Recent Development
11.5 Patheon (Thermo Fisher Scientific)
11.5.1 Patheon (Thermo Fisher Scientific) Company Details
11.5.2 Patheon (Thermo Fisher Scientific) Business Overview
11.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Introduction
11.5.4 Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.5.5 Patheon (Thermo Fisher Scientific) Recent Development
11.6 IVC
11.6.1 IVC Company Details
11.6.2 IVC Business Overview
11.6.3 IVC Soft Capsules Drugs CMO Introduction
11.6.4 IVC Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.6.5 IVC Recent Development
11.7 EuroCaps
11.7.1 EuroCaps Company Details
11.7.2 EuroCaps Business Overview
11.7.3 EuroCaps Soft Capsules Drugs CMO Introduction
11.7.4 EuroCaps Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.7.5 EuroCaps Recent Development
11.8 Captek
11.8.1 Captek Company Details
11.8.2 Captek Business Overview
11.8.3 Captek Soft Capsules Drugs CMO Introduction
11.8.4 Captek Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.8.5 Captek Recent Development
11.9 Strides Pharma Science
11.9.1 Strides Pharma Science Company Details
11.9.2 Strides Pharma Science Business Overview
11.9.3 Strides Pharma Science Soft Capsules Drugs CMO Introduction
11.9.4 Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.9.5 Strides Pharma Science Recent Development
11.10 Lonza (Capsugel)
11.10.1 Lonza (Capsugel) Company Details
11.10.2 Lonza (Capsugel) Business Overview
11.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Introduction
11.10.4 Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.10.5 Lonza (Capsugel) Recent Development
11.11 Soft Gel Technologies
11.11.1 Soft Gel Technologies Company Details
11.11.2 Soft Gel Technologies Business Overview
11.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Introduction
11.11.4 Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.11.5 Soft Gel Technologies Recent Development
11.12 Sirio Pharma
11.12.1 Sirio Pharma Company Details
11.12.2 Sirio Pharma Business Overview
11.12.3 Sirio Pharma Soft Capsules Drugs CMO Introduction
11.12.4 Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2016-2021)
11.12.5 Sirio Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Soft Capsules Drugs CMO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gelatin Type
Table 3. Key Players of Non-animal Type
Table 4. Global Soft Capsules Drugs CMO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Soft Capsules Drugs CMO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Soft Capsules Drugs CMO Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Soft Capsules Drugs CMO Market Share by Regions (2016-2021)
Table 8. Global Soft Capsules Drugs CMO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Soft Capsules Drugs CMO Market Share by Regions (2022-2027)
Table 10. Soft Capsules Drugs CMO Market Trends
Table 11. Soft Capsules Drugs CMO Market Drivers
Table 12. Soft Capsules Drugs CMO Market Challenges
Table 13. Soft Capsules Drugs CMO Market Restraints
Table 14. Global Soft Capsules Drugs CMO Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Soft Capsules Drugs CMO Market Share by Players (2016-2021)
Table 16. Global Top Soft Capsules Drugs CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Capsules Drugs CMO as of 2020)
Table 17. Ranking of Global Top Soft Capsules Drugs CMO Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs CMO Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Soft Capsules Drugs CMO Product Solution and Service
Table 21. Date of Enter into Soft Capsules Drugs CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2016-2021)
Table 25. Global Soft Capsules Drugs CMO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Soft Capsules Drugs CMO Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Soft Capsules Drugs CMO Revenue Market Share by Application (2016-2021)
Table 29. Global Soft Capsules Drugs CMO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Soft Capsules Drugs CMO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Soft Capsules Drugs CMO Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Soft Capsules Drugs CMO Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Soft Capsules Drugs CMO Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Soft Capsules Drugs CMO Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Soft Capsules Drugs CMO Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Soft Capsules Drugs CMO Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Soft Capsules Drugs CMO Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Soft Capsules Drugs CMO Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Soft Capsules Drugs CMO Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Soft Capsules Drugs CMO Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Soft Capsules Drugs CMO Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Soft Capsules Drugs CMO Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Soft Capsules Drugs CMO Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Soft Capsules Drugs CMO Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Soft Capsules Drugs CMO Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Soft Capsules Drugs CMO Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Soft Capsules Drugs CMO Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Soft Capsules Drugs CMO Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Soft Capsules Drugs CMO Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Soft Capsules Drugs CMO Market Size by Country (2022-2027) & (US$ Million)
Table 61. Catalent Company Details
Table 62. Catalent Business Overview
Table 63. Catalent Soft Capsules Drugs CMO Product
Table 64. Catalent Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 65. Catalent Recent Development
Table 66. Aenova Company Details
Table 67. Aenova Business Overview
Table 68. Aenova Soft Capsules Drugs CMO Product
Table 69. Aenova Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 70. Aenova Recent Development
Table 71. Nature's Bounty Company Details
Table 72. Nature's Bounty Business Overview
Table 73. Nature's Bounty Soft Capsules Drugs CMO Product
Table 74. Nature's Bounty Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 75. Nature's Bounty Recent Development
Table 76. Procaps Company Details
Table 77. Procaps Business Overview
Table 78. Procaps Soft Capsules Drugs CMO Product
Table 79. Procaps Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 80. Procaps Recent Development
Table 81. Patheon (Thermo Fisher Scientific) Company Details
Table 82. Patheon (Thermo Fisher Scientific) Business Overview
Table 83. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product
Table 84. Patheon (Thermo Fisher Scientific) Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 85. Patheon (Thermo Fisher Scientific) Recent Development
Table 86. IVC Company Details
Table 87. IVC Business Overview
Table 88. IVC Soft Capsules Drugs CMO Product
Table 89. IVC Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 90. IVC Recent Development
Table 91. EuroCaps Company Details
Table 92. EuroCaps Business Overview
Table 93. EuroCaps Soft Capsules Drugs CMO Product
Table 94. EuroCaps Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 95. EuroCaps Recent Development
Table 96. Captek Company Details
Table 97. Captek Business Overview
Table 98. Captek Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 99. Captek Recent Development
Table 100. Strides Pharma Science Company Details
Table 101. Strides Pharma Science Business Overview
Table 102. Strides Pharma Science Soft Capsules Drugs CMO Product
Table 103. Strides Pharma Science Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 104. Strides Pharma Science Recent Development
Table 105. Lonza (Capsugel) Company Details
Table 106. Lonza (Capsugel) Business Overview
Table 107. Lonza (Capsugel) Soft Capsules Drugs CMO Product
Table 108. Lonza (Capsugel) Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 109. Lonza (Capsugel) Recent Development
Table 110. Soft Gel Technologies Company Details
Table 111. Soft Gel Technologies Business Overview
Table 112. Soft Gel Technologies Soft Capsules Drugs CMO Product
Table 113. Soft Gel Technologies Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 114. Soft Gel Technologies Recent Development
Table 115. Sirio Pharma Company Details
Table 116. Sirio Pharma Business Overview
Table 117. Sirio Pharma Soft Capsules Drugs CMO Product
Table 118. Sirio Pharma Revenue in Soft Capsules Drugs CMO Business (2016-2021) & (US$ Million)
Table 119. Sirio Pharma Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Capsules Drugs CMO Market Share by Type: 2020 VS 2027
Figure 2. Gelatin Type Features
Figure 3. Non-animal Type Features
Figure 4. Global Soft Capsules Drugs CMO Market Share by Application: 2020 VS 2027
Figure 5. Health Supplements Case Studies
Figure 6. Pharmaceutical Case Studies
Figure 7. Others Case Studies
Figure 8. Soft Capsules Drugs CMO Report Years Considered
Figure 9. Global Soft Capsules Drugs CMO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Soft Capsules Drugs CMO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Soft Capsules Drugs CMO Market Share by Regions: 2020 VS 2027
Figure 12. Global Soft Capsules Drugs CMO Market Share by Regions (2022-2027)
Figure 13. Global Soft Capsules Drugs CMO Market Share by Players in 2020
Figure 14. Global Top Soft Capsules Drugs CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Capsules Drugs CMO as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Soft Capsules Drugs CMO Revenue in 2020
Figure 16. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2016-2021)
Figure 17. Global Soft Capsules Drugs CMO Revenue Market Share by Type (2022-2027)
Figure 18. North America Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Soft Capsules Drugs CMO Market Share by Type (2016-2027)
Figure 20. North America Soft Capsules Drugs CMO Market Share by Application (2016-2027)
Figure 21. North America Soft Capsules Drugs CMO Market Share by Country (2016-2027)
Figure 22. United States Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Soft Capsules Drugs CMO Market Share by Type (2016-2027)
Figure 26. Europe Soft Capsules Drugs CMO Market Share by Application (2016-2027)
Figure 27. Europe Soft Capsules Drugs CMO Market Share by Country (2016-2027)
Figure 28. Germany Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Soft Capsules Drugs CMO Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Soft Capsules Drugs CMO Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Soft Capsules Drugs CMO Market Share by Region (2016-2027)
Figure 38. China Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Soft Capsules Drugs CMO Market Share by Type (2016-2027)
Figure 46. Latin America Soft Capsules Drugs CMO Market Share by Application (2016-2027)
Figure 47. Latin America Soft Capsules Drugs CMO Market Share by Country (2016-2027)
Figure 48. Mexico Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Soft Capsules Drugs CMO Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Soft Capsules Drugs CMO Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Soft Capsules Drugs CMO Market Share by Country (2016-2027)
Figure 54. Turkey Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Soft Capsules Drugs CMO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Catalent Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 58. Aenova Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 59. Nature's Bounty Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 60. Procaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 61. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 62. IVC Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 63. EuroCaps Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 64. Captek Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 65. Strides Pharma Science Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 66. Lonza (Capsugel) Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 67. Soft Gel Technologies Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 68. Sirio Pharma Revenue Growth Rate in Soft Capsules Drugs CMO Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---